Curative Biosciences Stock Performance
| CBDX Stock | USD 0.0001 0.00 0.00% |
The firm shows a Beta (market volatility) of -2.1, which signifies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Curative Biosciences are expected to decrease by larger amounts. On the other hand, during market turmoil, Curative Biosciences is expected to outperform it. Curative Biosciences right now shows a risk of 0.0%. Please confirm Curative Biosciences information ratio and rate of daily change , to decide if Curative Biosciences will be following its price patterns.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Curative Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Curative Biosciences is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Free Cash Flow | -12.8 K |
Curative |
Curative Biosciences Relative Risk vs. Return Landscape
If you would invest 0.01 in Curative Biosciences on August 25, 2024 and sell it today you would earn a total of 0.00 from holding Curative Biosciences or generate 0.0% return on investment over 90 days. Curative Biosciences is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of pink sheets are less volatile than Curative, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Curative Biosciences Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Curative Biosciences' investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Curative Biosciences, and traders can use it to determine the average amount a Curative Biosciences' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CBDX |
Based on monthly moving average Curative Biosciences is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Curative Biosciences by adding Curative Biosciences to a well-diversified portfolio.
Curative Biosciences Fundamentals Growth
Curative Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Curative Biosciences, and Curative Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Curative Pink Sheet performance.
| Return On Asset | -38.44 | |||
| Current Valuation | 9.68 M | |||
| Shares Outstanding | 31.57 M | |||
| EBITDA | (50.35 K) | |||
| Cash And Equivalents | 982 | |||
| Total Debt | 156.45 K | |||
| Book Value Per Share | (0.04) X | |||
| Cash Flow From Operations | (12.8 K) | |||
| Earnings Per Share | (0.03) X | |||
| Total Asset | 2.27 K | |||
About Curative Biosciences Performance
Evaluating Curative Biosciences' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Curative Biosciences has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Curative Biosciences has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida. Curative Biosciences is traded on OTC Exchange in the United States.Things to note about Curative Biosciences performance evaluation
Checking the ongoing alerts about Curative Biosciences for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Curative Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Curative Biosciences generated a negative expected return over the last 90 days | |
| Curative Biosciences has some characteristics of a very speculative penny stock | |
| Curative Biosciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (53.2 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Curative Biosciences currently holds about 982 in cash with (12.8 K) of positive cash flow from operations. | |
| Roughly 76.0% of the company shares are held by company insiders |
- Analyzing Curative Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Curative Biosciences' stock is overvalued or undervalued compared to its peers.
- Examining Curative Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Curative Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Curative Biosciences' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Curative Biosciences' pink sheet. These opinions can provide insight into Curative Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Curative Pink Sheet Analysis
When running Curative Biosciences' price analysis, check to measure Curative Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biosciences is operating at the current time. Most of Curative Biosciences' value examination focuses on studying past and present price action to predict the probability of Curative Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biosciences' price. Additionally, you may evaluate how the addition of Curative Biosciences to your portfolios can decrease your overall portfolio volatility.